In The News: Nevada Institute of Personalized Medicine
It turns out you really are what you eat, according to UNLV scientists who have publicly launched a site that uses computer software to scan users’ DNA for potential health problems and create personalized diets that help lower the risks.
Martin Schiller’s research lab at UNLV is creating far more than just experiments. The research completed inside the Schiller Laboratory of Applied Bioinformatics has led to Schiller’s Heligenics, a startup that could help genetics testing companies shine a light on undiagnosed diseases.
With a new $11.4 million grant from the National Institutes of Health, UNLV wants to help the country move to a more data-driven approach to medicine.
This week UNLV was awarded an $11.4 million grant from the National Institute of Health to advance the university’s efforts in personalized medicine.
On May 6, the “All of Us” study started enrolling participants. This national study will be one of the largest ever examining the connection between genetics, behavior and medical outcomes, with a goal of 1 million or more participants. Anyone over the age of 18 in the U.S. can join.
A revolution is taking place in medication and the Nevada Institute of Personalized Medicine at UNLV is at the forefront.
Perhaps this was on your mind this morning when you were getting ready for work: Pressure-induced Tetrahedral to Orthombic Phase Transition in MgF2.
From injectable HIV meds via CytoDyn's PRO 140 to HIV prevention via PrEP, from subdermal implants and cellular scissors to x-ray crystallography, this has been an amazing year for medical breakthroughs in HIV. Here's a roundup of some of the hottest new advances and studies in the field.
It was 34 years ago, in 1981, that the first patients of the HIV virus were identified. Today, there remain 36.9 million people worldwide living with HIV.
It was 34 years ago, in 1981, that the first patients of the HIV virus were identified. Today, there remain 36.9 million people worldwide living with HIV.
With millions of people infected with the HIV virus world-wide, a cure has yet to be found. The reason why vaccines and drugs are so hard to develop for this virus relates to both mutation and latency of the virus.
A collection of biological codes sits in a library at UNLV. Much of the focus is learning how the codes can help cells fight off HIV. Researchers hope this work can be used to develop drugs much faster.